<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00891163</url>
  </required_header>
  <id_info>
    <org_study_id>EN3274-101</org_study_id>
    <nct_id>NCT00891163</nct_id>
  </id_info>
  <brief_title>Evaluate the Depth and Duration of Anesthesia</brief_title>
  <official_title>A Randomized, Double-Blind, Two-Period, Crossover Study to Evaluate the Depth and Duration of Anesthesia of Synera™ Patches Compared to Placebo Patches Applied to Healthy Adult Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ZARS Pharma Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Endo Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>ZARS Pharma Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine the depth (mm) of anesthesia provided by the Synera
      topical patch (using sensory depth and pain depth evaluations), and to determine the duration
      (minutes) of anesthesia provided by the Synera topical patch (using dermal sensory testing
      and thermal sensory testing evaluations), compared with a matching heated placebo patch.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2006</start_date>
  <completion_date type="Actual">April 2007</completion_date>
  <primary_completion_date type="Actual">April 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensory and pain depth measurements</measure>
    <time_frame>0, 30, 60, 90, 120 and 150 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Dermal and thermal sensory testing evaluations</measure>
    <time_frame>0, 30, 60, 90, 120 and 150 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess the safety and tolerability of the Synera topical patch compared with a matching heated placebo patch</measure>
    <time_frame>Throughout the study</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate local effects on the skin at the site of patch application for dermal adverse events (AEs)</measure>
    <time_frame>Throughout the study</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Synera</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Synera™ Topical Patch (70 mg lidocaine/70 mg tetracaine)</intervention_name>
    <description>30 minute applicable on antecubital fossa</description>
    <arm_group_label>Synera</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Patch</intervention_name>
    <description>placebo</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Had no known significant diseases

          -  Normal 12-lead electrocardiogram

          -  Willing to refrain from using any local topical preparations

        Exclusion Criteria:

          -  Taken over-the-counter (OTC) or prescription analgesics in any form within 24 hours

          -  Known allergy or sensitivity to any component of the Synera patch, including
             lidocaine, sympathomimetic amines, other local anesthetics of the amide type,
             epinephrine, or other patch components

          -  Had an active dermatological disease of any origin that may have interfered with their
             ability to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>UCSD Medical Center, Thornton Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92037-7651</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2009</study_first_submitted>
  <study_first_submitted_qc>April 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 1, 2009</study_first_posted>
  <last_update_submitted>April 30, 2009</last_update_submitted>
  <last_update_submitted_qc>April 30, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 1, 2009</last_update_posted>
  <responsible_party>
    <name_title>Senior Director, Clinical R&amp;D</name_title>
    <organization>Endo Pharmaceuticals Inc.</organization>
  </responsible_party>
  <keyword>Topical anesthesia</keyword>
  <keyword>Analgesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Tetracaine</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>March 22, 2012</submitted>
    <returned>April 17, 2012</returned>
    <submitted>May 16, 2012</submitted>
    <returned>June 14, 2012</returned>
    <submitted>June 25, 2012</submitted>
    <returned>July 25, 2012</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

